Sasol Limited Down Over 9%, On Track for Largest Percent Decrease Since October 2022 — Data Talk
Sasol Limited Sponsored ADR (SSL) is currently at $7.20, down $0.73 or 9.14%
--Would be lowest close since March 18, 2024, when it closed at $7.15
--On pace for largest percent decrease since Oct. 20, 2022, when it fell 9.4%
--Currently down seven of the past eight days
--Currently down three consecutive days; down 12.98% over this period
--Worst three day stretch since the three days ending June 18, 2021, when it fell 13.29%
--Down 7.75% month-to-date; on pace for worst month since Feb. 2024, when it fell 11.35%
--Down 27.52% year-to-date
--Down 89.1% from its all-time closing high of $66.09 on May 20, 2008
--Down 42.22% from 52 weeks ago (April 25, 2023), when it closed at $12.47
--Down 49.86% from its 52-week closing high of $14.37 on June 15, 2023
--Up 0.77% from its 52-week closing low of $7.15 on March 18, 2024
--Traded as low as $7.09; lowest intraday level since Nov. 16, 2020, when it hit $7.05
--Down 10.59% at today's intraday low; largest intraday percent decrease since Nov. 30, 2020, when it fell as much as 12.79%
All data as of 11:51:15 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 23, 2024 12:09 ET (16:09 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?